At Enventure, we are committed to a transparent and forward-thinking investment strategy that drives innovation and sustainable growth. Our approach is rooted in deep market insights, strategic partnerships, and a vision for long-term value creation.
The Q4 2024 Emerging Tech Indicator (ETI) report reveals a strategic shift towards fewer but larger deals, reflecting investor confidence in high-value investments despite a slight dip in deal volume from 179 to 175 and funding from $5.2B to $5.1B. AI & ML remained the dominant vertical, securing $1.5B across 37 deals, led by Poolside’s $500M Series B and Physical Intelligence’s $400M Series A. Climate tech saw a significant surge to $1B, driven by Pacific Fusion’s $900M Series A, highlighting a growing focus on renewable energy and sustainability.
Health & wellness tech rebounded after a Q3 dip, reaching $355.8M across 18 deals, with notable funding for Soda Health and Paradigm Health. DevOps also experienced substantial growth, rising to $283M across 9 deals, led by Tessl’s $100M Series A for AI-driven code generation.
These trends indicate a strong focus on practical applications of AI and sustainable innovation, signaling a new phase in emerging tech investments. Stay ahead of the curve by exploring our in-depth analysis and strategic insights in the full blog!
.jpg?width=1920&height=1080&name=Enventure%20(10).jpg)
The US healthcare sector saw a 30% drop in M&A activity in 2024 amid high valuations and regulatory challenges. Consolidation remained strong, with hospitals expanding non-acute services. Private equity focused on scalable healthcare tech and behavioral health. Enventure offers strategic guidance to navigate the evolving M&A landscape.
.jpg?width=1920&height=1080&name=Enventure%20(4).jpg)
The Q1 2025 VC Outlook shows exits stalling as investor strategies shift amid Nasdaq's 10% correction. VC-backed IPOs fell 8% from Q4 2024, with liquidity focused on a few unicorns. Tech startups secured 60% of funding, while megafunds raised 70% of capital, leaving smaller funds struggling. Early-stage funding dropped 5%, reflecting caution. With only 2 VC-backed IPOs, the lowest since 2016, investors focus on long-term value in AI, cybersecurity, and deep tech. Is recovery on the horizon?
STAY UP TO DATE
Total Posts: 100
Discover why secondary buyouts in private equity are becoming the go-to exit strategy. Learn how SBOs offer quicker exits, higher valuations, and...
Explore key private equity exit strategies in 2025—IPOs, sales, buyouts & more—for maximizing returns in a dynamic market.
AI is driving green tech growth in grid optimization, nuclear fusion, and energy-efficient data centers. Emerging markets like India are key to...
Discover how generational shifts in family businesses are reshaping private equity (PE) strategies. Learn how next-gen leaders are embracing external...
Explore how leveraged buyouts (LBOs) are reshaping private equity investments in family businesses, driving growth, and addressing succession...
Explore key exit strategies for family-owned business private equity investments, including IPOs, strategic sales, MBOs, and secondary...
Explore the growing role of private equity in India’s family-owned businesses, highlighting key opportunities, risks, and market trends shaping the...
Discover how private equity firms help family-owned businesses grow by modernizing operations and scaling sustainable.without losing their legacy or...
Explore why family businesses are increasingly partnering with private equity (PE) for growth and succession planning. Learn how PE provides capital,...
Tariff uncertainty is pausing deals, pushing investors to rethink value, resilience, and the new normal in global private equity.
US PE market enters 2025 with cautious optimism. Deal volume rises to 1,225, driven by healthcare buyouts. Exit activity remains robust despite...
Q4 2024 Healthcare IT PE Update: Steady deal volume amid economic challenges. Major buyouts include R1 RCM ($7.9B) and AdvancedMD ($1.13B)
Navigating tariff changes? Enventure offers strategic solutions for family businesses in the US & India. Learn how private equity can turn turbulence...
Q4 2024 ETI Report: High-value investments dominate as AI & ML lead, climate tech surges, and health tech rebounds. Discover emerging trends and...
Healthtech VC trends in Q4 2024 show resilience amid challenges. Discover investment insights, major deals, and how Enventure supports strategic...
Explore healthcare M&A trends in 2024 and how Enventure guides organizations through strategic growth amid challenges. Navigate the headwinds with us!
Healthtech VC rebounds in Q4 2024 with major deals and AI focus. Enventure helps innovators scale, optimize, and prepare for exits in a dynamic...
VC-backed exits hit record lows as IPOs decline. Investors shift to alternative liquidity strategies while capital flows selectively into tech and...
Global investors are betting big on India as private capital soars. Key sectors: GreenTech, AI, SpaceTech & semiconductors, fueled by policy support.
Earth observation tech is transforming climate action, driving sustainability, and fueling economic growth. Learn how data is shaping a greener...
Private equity lags public markets, & VC faces a 3-year slump, but new opportunities are emerging. Enventure is built to win in this evolving...
$58.7B raised, 28% YoY growth, booming exits! This report explores key AI & ML investment trends, major deals, and why investors should take notice.
AI is transforming healthcare, and private equity in the lower middle market is scaling proven AI-driven companies for growth, innovation, and...
Let's team up and make a difference.
Enventure is an exit-driven fund with high-yield opportunities in the healthcare, space, and green tech sectors across the US and India.
3103 Kewanee Ln,
Naperville, IL, 60564
Copyright © 2025 Enventure, all rights reserved.